Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Ruggieri

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Neurology|November 4, 2024
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration GapGiuseppe Pontillo, Ferran Prados, Jordan Colman, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Neurology|November 4, 2024
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration GapGiuseppe Pontillo, Ferran Prados, Jordan Colman, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 11